Similar Articles
1391 Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients
1392 Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
1393 Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma
1394 Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
1395 Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma
1396 Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
1397 Prevention and not merely prediction of preterm labor and delivery
1398 Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
1399 High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: Assessment with liver computed tomography
1400 Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA